CAMPOSTRINI, Natascia
 Distribuzione geografica
Continente #
NA - Nord America 3.343
EU - Europa 2.322
AS - Asia 1.789
SA - Sud America 272
AF - Africa 21
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.755
Nazione #
US - Stati Uniti d'America 3.309
GB - Regno Unito 861
CN - Cina 691
SG - Singapore 652
SE - Svezia 247
BR - Brasile 234
FR - Francia 220
HK - Hong Kong 206
DE - Germania 192
RU - Federazione Russa 184
FI - Finlandia 181
IE - Irlanda 181
IT - Italia 104
UA - Ucraina 61
VN - Vietnam 50
JP - Giappone 39
KR - Corea 37
IN - India 25
BE - Belgio 24
CA - Canada 23
TR - Turchia 23
NL - Olanda 20
AR - Argentina 14
BD - Bangladesh 11
IR - Iran 9
ES - Italia 8
IQ - Iraq 8
AT - Austria 7
PL - Polonia 7
AU - Australia 6
MX - Messico 6
VE - Venezuela 6
EC - Ecuador 5
ID - Indonesia 5
MA - Marocco 5
ZA - Sudafrica 5
CL - Cile 4
HR - Croazia 4
LT - Lituania 4
UZ - Uzbekistan 4
CH - Svizzera 3
DZ - Algeria 3
EG - Egitto 3
GR - Grecia 3
IL - Israele 3
PK - Pakistan 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CO - Colombia 2
CZ - Repubblica Ceca 2
EU - Europa 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MD - Moldavia 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
SA - Arabia Saudita 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
DK - Danimarca 1
HN - Honduras 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
ME - Montenegro 1
MU - Mauritius 1
MW - Malawi 1
MZ - Mozambico 1
NI - Nicaragua 1
OM - Oman 1
PH - Filippine 1
SV - El Salvador 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
Totale 7.755
Città #
Southend 733
Chandler 513
Jacksonville 480
Woodbridge 340
Singapore 337
Dallas 254
Ann Arbor 234
Hong Kong 201
Houston 194
Dublin 181
Ashburn 154
Beijing 124
Lawrence 77
Princeton 77
New York 75
Wilmington 69
Lancaster 63
Nanjing 61
Jinan 59
Munich 48
The Dalles 43
Tokyo 39
Boardman 38
Verona 37
Los Angeles 36
Shenyang 34
Helsinki 30
Columbus 28
Nanchang 25
Brussels 22
Hebei 22
Ho Chi Minh City 21
Sindelfingen 21
São Paulo 21
Changsha 20
Jiaxing 20
Buffalo 19
Haikou 19
Hangzhou 19
Zhengzhou 19
Santa Clara 18
Guangzhou 17
Milan 16
Ningbo 16
Norwalk 16
Taizhou 15
Tianjin 14
Brooklyn 13
Taiyuan 13
Turku 13
London 12
Redmond 12
San Francisco 11
Lanzhou 10
Redondo Beach 10
Seattle 10
Fairfield 9
Hanoi 9
San Mateo 9
Toronto 9
Fuzhou 8
Dearborn 7
Rio de Janeiro 7
Stockholm 7
Ardabil 6
Belo Horizonte 6
Brasília 6
Falls Church 6
Montreal 6
Washington 6
Bologna 5
Boston 5
Chennai 5
Nuremberg 5
Shanghai 5
Warsaw 5
Ankara 4
Baghdad 4
Campinas 4
Chicago 4
Düsseldorf 4
Kochi 4
Madrid 4
Nettuno 4
Porto Alegre 4
Tashkent 4
Thái Nguyên 4
Vienna 4
Aligarh 3
Athens 3
Bangalore 3
Can Tho 3
Casablanca 3
Caxias do Sul 3
Charlotte 3
Clearwater 3
Council Bluffs 3
Curitiba 3
Detroit 3
Dhaka 3
Totale 5.238
Nome #
MOLECULARLY IMPRINTED NANOPARTICLES FOR HEPCIDIN CAPTURE: A SYNTHETIC ALTERNATIVE TO NATURAL ANTIBODIES 153
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 148
The proteome: anno Domini 2002 143
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 142
Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload 135
“Proteome analysis in the clinical chemistry laboratory: myth or reality?” 127
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 126
Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study. 126
Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system 124
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 124
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 124
“Proteomics approaches for studying chemoresistance in cancer” 123
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian Patients with Iron Overload and Non-Diagnostic First Level Genetic Test: A Pilot Study 123
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin 122
HEPCIDIN REPRESSION BY PROMOTER DNA HYPERMETHYLATION IN NON-VIRAL HEPATOCELLULAR CARCINOMA 122
A Gain-of-Function Mutation on BCKDK Gene and Its Possible Pathogenic Role in Branched-Chain Amino Acid Metabolism 122
A proteomic approach for evaluating the cell response to a novel histone deacetylase inhibitor in colon cancer cells. 121
Anticancer activity of a novel histone deacetylase inhibitor against human colorectal cancer cells 121
Altered paraoxonase expression in patients with genetic haemochromatosis. 120
A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients? 120
“Application of Partial Least Squares Discriminant Analysis and variable selection procedures: a 2D-PAGE Proteomic-Based Study” 119
“Critical survey of quantitative proteomics in two-dimensional electrophoretic approaches” 116
Hepcidin Inhibition by Modified Heparins without Anticoagulant Activity 116
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 115
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 115
“Pre-fractionation for Hidden Proteome” 111
TMPRSS6 rs855791 modulates hepcidin transcription in vitro and serum hepcidin levels in normal individuals. 111
“Numerical approaches for quantitative analysis of 2D map: a review of commercial software and of “home-made” systems” 110
"Quantitative Proteomics" 110
Detection of a rare mutation in the ferroportin gene through targeted next generation sequencing. 109
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 108
Hepcidin levels and their determinants in different types of myelodysplastic syndromes. 108
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents 108
“Conventional isoelectric focusing in gel slabs and capillaries and immobilized pH gradients” 107
Proteomic analysis of S-nitrosylated proteins in Arabidopsis thaliana undergoing hypersensitive response 107
High-protein goat's milk diet identified through newborn screening: clinical warning of a potentially dangerous dietetic practice 106
Serum Hepcidin Levels Correlate with Phenotypes of the Metabolic Syndrome At Population Level 105
Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. 104
High resolution preparation of monocyte-derived macrophages (MDM) protein fractions for clinical proteomics 104
Acquired iron overload associated with antitransferrin monoclonal immunoglobulin: a case report. 102
Association ofHFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations. 100
Serum Hepcidin in Inflammatory Bowel Diseases: biological and clinical significance. 99
Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo. 99
Does TMPRSS6 RS855791 Polymorphism Contribute to Iron Deficiency in Treated Celiac Disease? 99
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. 96
Proteomic analysis of an orthotopic neuroblastoma xenograft animal model. 96
Reduced serum hepcidin levels in patients with chronic hepatitis C 96
Quantitative proteomics: a review of different methodologies. 95
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 94
Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity 93
Newborn Screening for Biotinidase Deficiency. The Experience of a Regional Center in Italy 92
The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis. 90
Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience 90
Proteomic analysis of S-nitrosylated proteins in Arabidopsis during the disease resistance response 87
Study of proteomic changes associated with healthy and tumoral murine samples in neuroblastoma by principal component analysis and classification methods. 86
Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron. 86
Serum hepcidin levels and muscle iron proteins in humans injected with low- or high-dose erythropoietin 85
Urinary hepcidin identifies a serum ferritin cut-off for iron supplementation in young athletes: a pilot study. 84
Proteomic analysis of anti-angiogenic effects by a combined treatment with vinblastine and rapamycin in an endothelial cell line. 82
Hepcidin assay in serum by SELDI-TOF-MS and other approaches 80
Measurament of urinary hepcidin levels by self-tof-ms in HFE-hemochromatosis 79
Spot overlapping in two-dimensional maps: a serious problem ignored for much too long. 79
Toward Worldwide Hepcidin Assay Harmonization: Identification of a Commutable Secondary Reference Material 79
Formation of truncated proteins and high-molecular-mass aggregates upon soft illumination of photosynthetic proteins. 76
Two-dimensional mapping as a tool for classification of green coffee bean species. 74
Omics | quantitative proteomics 74
PON1 activity and coagulation biomarkers: no association with thrombin generation parameters but an inverse correlation with D-dimer plasma concentration 73
Serum Hepcidin and Iron Absorption in Paediatric Inflammatory Bowel Disease 72
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization 68
HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients. 68
Hepcidin levels in chronic hemodialysis patients: a critical evaluation. 68
Iron deficiency in the elderly population, revisited in the hepcidin era. 67
Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo 65
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian patients with Iron Overload and Non-diagnostic First Level Genetic Test.A Pilot Study 63
Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo. 62
Novel TMPRSS6 mutations associated with iron-refractory iron deficiency anemia (IRIDA) 61
Vitamin B12 Administration by Subcutaneous Catheter Device in a Cobalamin A (cblA) Patient 60
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 34
Totale 7.808
Categoria #
all - tutte 28.714
article - articoli 21.182
book - libri 0
conference - conferenze 6.039
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.493
Totale 57.428


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021463 0 0 29 75 102 62 9 45 34 11 88 8
2021/2022547 34 145 11 65 20 16 6 27 20 15 62 126
2022/20231.345 90 142 129 216 146 317 23 79 156 4 27 16
2023/2024603 24 48 39 51 76 126 14 35 4 11 120 55
2024/20251.497 67 103 63 274 62 68 60 46 233 84 125 312
2025/2026881 344 283 254 0 0 0 0 0 0 0 0 0
Totale 7.808